The Supreme Court unanimously ruled Thursday that human genes cannot be patented.
But in something of a compromise decision, all nine justices said a synthetic version of the gene material may be patented.
Initial reaction from investors sent the stock of Myriad Genetics, the company involved, higher.

--This was the text of a CNN news alert today..
First paragraph good.
Second? Not so much